Genovis AB Series B | Balance Sheet

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
3,480.40
5,688.80
2,052.50
4,281.30
4,917.70
Total Accounts Receivable
26,755.90
2,417.80
2,956.20
5,057.30
4,872.40
Inventories
484.50
865.40
960.40
1,503.40
3,169.50
Other Current Assets
1,319.00
1,131.30
4,849.20
4,770.00
4,563.70
Total Current Assets
32,039.80
10,103.20
10,818.30
15,612.00
17,523.30
Net Property, Plant & Equipment
1,810.30
2,307.20
1,756.50
1,083.50
3,021.90
Intangible Assets
4,162.00
5,434.10
2,621.50
3,438.00
4,042.20
Total Assets
41,448.10
19,562.50
16,914.30
21,851.50
26,305.50
ST Debt & Current Portion LT Debt
-
45.50
45.50
134.80
351.50
Accounts Payable
3,556.60
986.30
945.10
1,551.70
1,332.50
Other Current Liabilities
4,806.50
3,767.10
6,966.90
4,619.80
4,679.40
Total Current Liabilities
8,363.10
4,798.80
7,957.50
6,306.40
6,363.40
Long-Term Debt
-
180.30
134.80
-
1,755.40
Deferred Taxes
3,436.00
1,718.00
1,718.00
1,718.00
1,718.00
Total Liabilities
8,363.10
4,979.10
8,092.30
6,306.40
8,118.80
Common Equity (Total)
33,085.00
14,583.40
8,822.00
15,545.10
18,186.70
Total Shareholders' Equity
33,085.00
14,583.40
8,822.00
15,545.10
18,186.70
Total Equity
33,085.00
14,583.40
8,822.00
15,545.10
18,186.70
Liabilities & Shareholders' Equity
41,448.10
19,562.50
16,914.30
21,851.50
26,305.50

About Genovis AB

View Profile
Address
Scheelevägen 2
Lund SN 220 07
Sweden
Employees -
Website http://www.genovis.com
Updated 09/14/2018
Genovis AB engages in the development and market of nanotechnology. It develops, produces and markets technologies that facilitate and enable development of new treatment methods and diagnostics for customers in the medical device and pharmaceutical industries. The company was founded by Inga Sarah Maria Fredriksson in 1999 and is headquartered in Lund, Sweden.